At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Senior health economics role in US HEOR to lead strategic, scientific, and policy-shaping projects that demonstrate the value of medicine
Roles and Responsibilities
* Support the development of an aligned strategy for US Health Economics and Outcomes Research (HEOR) to demonstrate the value of BMS products in a meaningful way to healthcare stakeholders including patients, providers and payers.
* Effectively lead scientifically rigorous HEOR studies and manage projects from concept through full execution, including reporting the evidence at scientific congresses, in peer reviewed publications, and proactive/reactive BMS communication tools.
* Establish strong relationships with external agencies and key opinion leaders and represent the HEOR function at major medical meetings.
* Establish strong cross-functional relationships with internal BMS and alliance stakeholders.
* Be viewed of as an internal HEOR expert who is fully integrated into the BMS matrix team and provides critical input into the development of effective communication tools and programs for optimal market access.
* Demonstrate the ability to make decisions on selecting external organizations and researchers with appropriate expertise for research collaborations.
* Strive to demonstrate BMS behaviors of Passion, Speed, Innovation, and Accountability
Requirements
* Graduate degree required (MD, PhD, MS, MPH, PharmD).
* Five plus years previous experience working in outcomes research, health economics or epidemiology in the pharmaceutical industry.
* Ability to lead a cross functional team and influence without formal authority
* Ability to understand, interpret, and make recommendations concerning the evolving US market.
* Demonstrated ability to work effectively with strong problem solving and communications skills.
* Previous experience executing research and managing projects independently.
* Relevant scientific experience in clinical setting or within pharmaceutical industry.
* Previous experience in publishing scientific data.
* Advanced degree in health science with strong scientific publication track record.
* In depth understanding of healthcare economics, epidemiology, quality of life and clinical research.
* Strong understanding of US payer and market access challenges.
* In depth understanding of statistical methods and tests. Strong knowledge of pharmaceutical development and product promotion.
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or any part of the recruitment process direct your inquiries to adastaffingsupport@bms.com. Visit careers.bms.com/eeo-accessibility to access our complete Equal Employment Opportunity statement.
New York, New York
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.
It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.
The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.